Rethinking Dosimetry: The Perils of Extrapolated External-Beam Radiotherapy Constraints to Radionuclide Therapy @thomashopemd@altoubaht#JonathanStrosberg
Just out @JournalofNucMed
https://t.co/4cPQkimU15
#theranostics: "Dosimetry sits at a crossroads. It is time to move away from extrapolating external-beam–defined normal-organ constraints to RNT. Direct observation of adverse effects is simpler and superior. We must still monitor for longer-term adverse effects, especially within organs of interest. Advances in quantitative SPECT/CT and software open new opportunities to redefine the use of dosimetry to improve patient outcomes. Undoubtedly, there are superior personalized administration schedules that modulate the amount and frequency of the administered activity. However, only well-designed randomized clinical trials with long-term follow-up can accurately evaluate whether novel dosimetry-based prescriptions are superior to fixed schedules. As with any other oncologic therapy, the burden of proof is on us to demonstrate that these strategies yield superior efficacy or safety outcomes. We hope that improved evidence-based strategies will be developed to improve patient care."
Sitting here at #ESMO23 watching randomized data on thousands of patients showing (yet again) that immunotherapy doesn’t improve outcomes for prostate cancer patients. And causes lots of side-effects. Give up folks!
PSMA PET Academy: started with a blank sheet of paper and turned into 12 educational videos with already more than 50,000 views. Huge thanks to the outstanding faculty, the superb steering committee, the sponsors and UroToday.
@PCFnews@urotoday@pros_tic
APPLICATION now Open - ESMO EANM Advanced Course on Theranostics, 19-20 May 2023, Essen, 🇩🇪. Including great lectures, discussions and excellent faculty. @AOmlin @KatharinaLueck1 @stefanofanti4 @ViktorGruenwald https://t.co/LwFBqp6c5A
Found a new podcast to help me get my geek on.
Might have to start one of these to raise #Radioligandtherapy awareness in Switzerland.
Great job @sam_nordic and @GustavWidar!
If you want to learn something new. I can strongly recommend to run a podcast and have the opportunity to invite the experts that can explain the new thing. Thank you @thomashopemd , Wolfgang Fendler, Kim Prabst and Silvi Telo explaining FAPi or maybe just FAP for me
Sunday morning, talking about prostate imaging and current status of PSMA, with three superstars! Thank you, Helle Damgaard Zacho, Simona Malaspina and Daniela Oprea-Lager
#EANM22
With only 1 day left, we're excited to announce the guests of the third episode of Theragnostic Talks @ EANM'22 Congress. @GustavWidar has the pleasure to talk about #FAPI with Dr. Wolfgang Fendler, Prof @thomashopemd, Kim M. Pabst, & Silvi Telo. Don't miss it, airing on Monday!
Starting on Saturday I will do a daily #Theragnostictalks podcast live at the #EANM´22 congress. To be sure you won’t miss an episode follow SAM Nordic here twitter or LinkedIn
If you are in Barcelona, see you there!
At #EANM22, the Theragnostic Talks podcast will cover the latest topics in Nuc Med, as it happens. @GustavWidar will talk with the foremost experts in this field, starting with @officialEANM President, Prof. Jolanta Kunikowska, and EANM Chair, Prof. @stefanofanti4. 👉Sat, Oct 15.
In 🇸🇪 we have a saying, it goes something like, “A beloved child has many names". Somewhat similar to “We find many names for those we love”. Theranostics or theragnostics, that is. We chose to spell it with a g. Why? Read the full story & get answers here:https://t.co/GBX0Q6B1Ji
In 🇸🇪 we have a saying, it goes something like, “A beloved child has many names". Somewhat similar to “We find many names for those we love”. Theranostics or theragnostics, that is. We chose to spell it with a g. Why? Read the full story & get answers here:https://t.co/GBX0Q6B1Ji
We are recruiting! Our very popular full-time unaccredited Urology Registrar position is available from Feb 2023 for one year. Superb GU Oncology team, huge research program, robotic surgery etc. Closing date for applications 21st Aug. Details here https://t.co/svTE4SEPX9